Impact of relative dose intensity in gemcitabine–cisplatin chemotherapy for metastatic urothelial carcinoma

Objectives: To evaluate the impact of relative dose intensity for gemcitabine–cisplatin chemotherapy in patients with metastatic urothelial carcinoma. Methods: We retrospectively reviewed the medical records of 18 patients with metastatic urothelial carcinoma, who received gemcitabine–cisplatin regi...

Full description

Bibliographic Details
Main Authors: Naoki Kohei, Kyohei Sugiyama, Ichiro Chihara, Yusuke Muro, Masaaki Imamura, Yasunori Nishio, Koji Yoshimura
Format: Article
Language:English
Published: SAGE Publishing 2018-06-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/2050312118783011